関連する実験動画
Updated: May 6, 2026
07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.8K
バース症候群を引き起こし,心臓移植につながる新しいTAFAZZIN遺伝子変異体c.525_533del:症例報告
Michał Krawiec1, Joanna Śliwka2, Szymon Pawlak2
1Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Frontiers in pediatrics
|September 3, 2025
まとめ
バース症候群は,TAFAZZIN遺伝子に影響する珍しい遺伝疾患で,重度の心臓疾患を引き起こす可能性があります. 新しい突然変異が心臓不全を引き起こし 機械的なサポートと移植が必要になりました
科学分野:
- 遺伝学
- 心臓病科
- 生物化学
背景:
- バース症候群 (BTHS) は,X関連TAFAZZIN遺伝子の変異によって引き起こされる極まれな遺伝疾患で,カルディオリピン代謝に影響します.
- タファジンタンパク質はミトコンドリアのリンパ脂代謝に不可欠であり,その機能不全は拡張性心筋病 (DCM) と中性不全を含む一連の症状を引き起こす.
研究 の 目的:
- BTHSを引き起こす,以前未確認の *TAFAZZIN* 遺伝子変異を報告する.
- BTHS患者の重度の心血管症状と管理について説明します.
- 機械的な循環支援と心臓移植を必要とするBTHS患者の管理の複雑さを強調する.
主な方法:
- *TAFAZZIN* 遺伝子変異を特定するための遺伝子配列解析
- BTHS,DCM,左心房非収縮の患者の臨床症例レビュー
- メカニカル循環支援 (MCS) とオーソトピック心臓移植 (OHT) を含む治療戦略の分析
主要な成果:
- 新しい *TAFAZZIN* 遺伝子変異種 (NM_000116. 4: c.525_533del; NP_000107. 1: p.
- 患者は重度のDCMを呈し,MCSと後にOHTが必要になった.
- 手術後の治療には,患者の中性子減少症による免疫抑制が必要でした.
結論:
- これまで報告されていない * TAFAZZIN * 遺伝子の変異は,BTHSを引き起こす可能性があります.
- MCSやOHTのような高度な介入が必要になる可能性があります.
- 移植を受けるBTHS患者では,中性不全などの併発症を慎重に管理することが不可欠です.
関連する概念動画
01:24Tissue Transplantation
1.4K
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
802
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
812
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
968
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968